Fatal hyperpyrexia caused by xylazine: a case report

3Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Xylazine is used in veterinary medicine as a sedative, analgesic, and muscle relaxant. However, in recent decades, it has frequently been detected in illicit drugs. Xylazine poisoning is characterized by depression of the central nervous and cardiovascular systems. Herein, we present a case of a 41-year-old man who not only had severe depression of the central nervous and cardiovascular systems, but also developed hyperpyrexia during the treatment of xylazine poisoning, which led to his death 3 days after poisoning. This case indicates that, in addition to its other effects, xylazine may also cause hyperthermia, which has not yet been reported in humans.

Cite

CITATION STYLE

APA

Dai, P., Chen, Y., Luo, X., Zhou, Z., Shi, M., Genjiafu, A., & Jian, X. (2024). Fatal hyperpyrexia caused by xylazine: a case report. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1437960

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free